Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

March 24, 2026 09:00 ET | Source: Gevo, Inc.

Gevo Positioned to Accelerate Global Expansion Through Licensing and Franchise Development Strategy

ENGLEWOOD, Colo., March 24, 2026 (GLOBE NEWSWIRE) -- Gevo, Inc. (NASDAQ: GEVO), a leader in sustainable fuels and carbon management, today highlights the strategic value of its intellectual property...
March 24, 2026 08:45 ET | Source: Propanc Biopharma, Inc.

Propanc Biopharma Executes Multi-Yr, Anti-Aging & Cancer Research Collaboration with the Universities of Jaén and Granada, Spain

The goal is to strengthen our intellectual property and to better understand how PRP technology can overcome resistant tumors and age-related diseases.
March 17, 2026 09:15 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine Announces Publication of Six Innovative Patents in Hong Kong for Next-Generation Psychedelic-Based Combination Therapies

Vancouver, Canada, March 17, 2026 (GLOBE NEWSWIRE) -- Clearmind Medicine Inc. (Nasdaq: CMND) (“Clearmind” or the "Company"), a clinical-stage biotech company focused on the discovery and development...
March 16, 2026 08:20 ET | Source: SciSparc Ltd

SciSparc: NeuroThera Labs- Clearmind Medicine Collaboration Leads to Patent Application for Depression Therapy

TEL AVIV, Israel, March 16, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage...
March 13, 2026 07:45 ET | Source: Clearmind Medicine Inc.

Clearmind Medicine Announces Hong Kong Patent Filing for Depression Therapy

Innovative non-hallucinogenic approach combines MEAI with Palmitoylethanolamide to tackle major depressive disorder, addressing a surging market expected to surpass $25 billion by 2030 Vancouver,...
March 12, 2026 07:55 ET | Source: SciSparc Ltd

SciSparc: NeuroThera Labs Announces Publication of International Patent in Collaboration with Clearmind Medicine for Novel Therapy Targeting Weight Loss and Fatty Liver Disease

TEL AVIV, Israel, March 12, 2026 (GLOBE NEWSWIRE) -- SciSparc Ltd. (Nasdaq: SPRC) (“Company” or “SciSparc”), today announced that NeuroThera Labs Inc. (TSXV: NTLX) ("NeuroThera"), a clinical-stage...
March 11, 2026 16:05 ET | Source: LogicMark, Inc.

LogicMark, Inc. to Announce Fourth Quarter and Full Year 2025 Financial Results on March 25, 2026

LOUISVILLE, Ky., March 11, 2026 (GLOBE NEWSWIRE) -- LogicMark, Inc. (OTC: LGMK), a provider of emergency response systems, health communications devices, and technology for the growing personal...
March 11, 2026 09:15 ET | Source: 24/7 Market News and Kraig Labs

24/7 Market News: Kraig Labs the Bootstrapped Unicorn in the Making

Unicorns are usually $1 billion private companies, backed by institutional players and Kraig Labs (OTCQB: KBLB) is advancing a $billion platform
March 02, 2026 09:06 ET | Source: Research and Markets

Patent Valuation Service Industry Report 2026-2035: A 3.99 Billion Market by 2030 with Kroll, Stout Risius Ross, FTI Consulting, CRA International, Metis Partners Leading

Dublin, March 02, 2026 (GLOBE NEWSWIRE) -- The "Patent Valuation Service Market Report 2026" has been added to ResearchAndMarkets.com's offering. The patent valuation service market is...
February 26, 2026 14:36 ET | Source: Digital Global Systems

Digital Global Systems Achieves $18B Patent Portfolio Valuation Amid Record Patent Momentum and Accelerated Issuances

TYSONS, Va., Feb. 26, 2026 (GLOBE NEWSWIRE) -- Digital Global Systems (DGS) announced that its patent portfolio was independently valued at approximately $18 billion as of November 15, 2025. Since...